RGAVX | VCRCX | RGAVX / VCRCX | |
Total Expense Ratio | 1.30 | 2.08 | 63% |
Annual Report Gross Expense Ratio | 1.42 | 2.10 | 68% |
Fund Existence | 9 years | 6 years | - |
Gain YTD | 15.801 | 7.675 | 206% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 1000 | 1000 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 123M | 917M | 13% |
Annual Yield % from dividends | 3.41 | 0.76 | 447% |
Returns for 1 year | 15.03 | 10.99 | 137% |
Returns for 3 years | 5.46 | 10.19 | 54% |
Returns for 5 years | 55.77 | 41.82 | 133% |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
NQP | 10.97 | N/A | N/A |
Nuveen Pennsylvania Quality Municipal Income Fund | |||
REGL | 80.60 | N/A | N/A |
ProShares S&P MidCap 400 Dividend Arst | |||
SELV | 30.76 | N/A | N/A |
SEI Enhanced Low Volatil US Lg Cap ETF | |||
IBRN | 22.31 | N/A | N/A |
iShares Neuroscience and Healthcare ETF | |||
SAGP | 31.39 | N/A | N/A |
Strategas Global Policy Opp ETF |